Platform
Company
Immunology & Autoimmune
Review status
Currently under review
Pending specialist review and validation.
This test measures the percentage of B lymphocytes in your blood using flow cytometry. It identifies white blood cells with CD45, then looks for cells that also carry CD19, a marker found on most B cells. The result is reported as the proportion of CD19‑positive cells within the white blood cell population analyzed.
B cells help your immune system by producing antibodies and supporting immune memory. Their proportion naturally varies with age and can change with infections, immune conditions, or treatments that affect lymphocytes. This test is often performed alongside other lymphocyte subset measurements and a complete blood count to give a broader view of immune status.
Your B cell percentage helps clinicians evaluate how well your immune system is functioning. It can assist in the workup of suspected primary immunodeficiencies, assessment of certain leukemias or lymphomas, and monitoring of immune recovery after treatments such as biologic therapies, chemotherapy, or stem cell transplant. It is also used to follow immune reconstitution and to interpret vaccine response testing when needed.
A result that is higher or lower than expected does not by itself diagnose a condition. Doctors interpret it together with your symptoms, examination, other blood tests, and medical history. Because several medications and temporary illnesses can shift lymphocyte percentages, your care team may repeat the test or add related studies before making decisions.
If your B cell percentage is lower than expected, it may reflect reduced B cell production or recovery, loss due to treatment, or a redistribution of lymphocytes during illness. If it is higher, it can be seen with certain immune responses or blood disorders. Trends over time, combined with absolute lymphocyte and B cell counts, often provide more insight than a single value.
Your clinician may correlate the result with other tests such as immunoglobulin levels and additional lymphocyte subsets. If medications, recent infections, or procedures could affect the measurement, they may recommend repeating the test after those factors resolve. Discuss any symptoms, recent therapies, and vaccination plans with your provider so results can be interpreted in the right context.
Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.
Treatments that target B cells, such as anti‑CD20 or anti‑CD19 agents and CAR‑T therapies, can markedly reduce circulating B cells for an extended period, lowering the measured percentage.
Viral infections, systemic inflammation, or stress responses can temporarily change lymphocyte trafficking and proportions, shifting the B cell percentage without indicating a chronic problem.
Flow cytometry requires fresh, well‑preserved cells. Delays in transport, improper storage temperature, or clotting can reduce cell viability and alter measured subsets.
Normal B cell proportions vary naturally with age. Infants and children often have different typical percentages than adults, so age‑appropriate interpretation is essential.
Medications such as systemic steroids or cytotoxic drugs can transiently decrease circulating lymphocytes or selectively impact B cells, affecting results.
After hematopoietic stem cell transplant or cytotoxic chemotherapy, immune reconstitution occurs in phases. B cell percentages can remain low or fluctuate during recovery.
References